Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-arterial Lidocaine and Methylprednisolone Injection Into the Middle Meningeal Artery For Treatment of Headache Associated With Subarachnoid Hemorrhage

NCT07054801 is registered in ClinicalTrials.gov with Daniel Raper, MBBS as lead sponsor.

NCT NCT07054801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07054801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-arterial Lidocaine and Methylprednisolone Injection Into the Middle Meningeal Artery For Treatment of Headache Associated With Subarachnoid Hemorrhage
Lead sponsor
Daniel Raper, MBBS
Phase
Phase 2
Overall status
Recruiting
Start date
June 23, 2026
Completion date
June 1, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headaches associated with subarachnoid hemorrhage (sah)